
News from Pharmaceutical Business review
Top Pharmaceutical Business Review News

AMD · United States The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due to age-related macular degeneration, according to a press release from Sanofi.See the Story
FDA Fast Tracks One-Time Intravitreal Gene Therapy for Geographic Atrophy
100% Center coverage: 2 sources

CancerNEEDHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that the European Medicines Agency (EMA) has granted Orphan Designation for CAN-2409 (aglatimagene besadenovec) for the treatment of pancreatic cancer. This designation complements CAN…See the Story
Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer - Candel Therapeutics (NASDAQ:CADL)
100% Center coverage: 1 sources